retatrutide and blood sugar New GLP-3 drug significantly slashes both weight levels in Phase III trial Retatrutide Guide 2023: Weight Loss,

Always use a new, sterile needle for each injection and never share devices with another person

Its also FDA-approved for weight loss and management in pediatric patients aged 12 and older with obesity

"Somewhere in the region of 60 to 80% of the weight that you lost will return." Ellen Ogley is determined not to let that happen

Understanding why it happens is the first step toward finding the right solution

Tirzepatide has been shown to be as potent or more potent than GLP-1 RAs in patients with or without diabetes

But 2026 does bring some alternative options, you can jump ahead to our What Else is New section to learn more